Published in J Exp Med on July 01, 1970
Cytotoxicity in graft-versus-host reaction. I. Role of donor and host spleen cells. J Exp Med (1972) 0.91
Serum-free culture of hamster lymphoid cells and differential inhibition of lipopolysaccharide stimulation by isologous serum. Infect Immun (1976) 0.88
Analysis of graft-versus-host disease in Syrian hamsters. IV. The refractory state and immunologic competence. J Exp Med (1972) 0.75
Anti-leukaemia activity as a bystander effect of graft-versus-host reactions. Br J Cancer (1976) 0.75
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
Quantitative studies on the induction of tolerance of skin homografts and on runt disease in neonatal rats. J Natl Cancer Inst (1962) 3.14
The biology of graft-versus-host reactions. Harvey Lect (1968) 2.35
Changes in the activity of the reticulo-endothelial system (RES) following the injection of parental spleen cells into F1 hybrid mice. Br J Exp Pathol (1961) 2.13
Immunization with skin isografts taken from tolerant mice. Science (1967) 2.05
Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon. J Exp Med (1968) 1.98
Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes. Science (1968) 1.69
Reactions of the graft versus host (GVH) type. Aust J Exp Biol Med Sci (1969) 1.49
Studies on delayed cutaneous inflammatory reactions elicited by inoculation of homologous cells into hamsters' skins. J Exp Med (1966) 1.39
Quaitative studies on antigenic recognition. I. Immunological and nonimmunological parameters of the response. J Exp Med (1969) 1.06
The lymph-node permeability factor: a possible mediator of experimental allergic thyroiditis in the rat. J Pathol Bacteriol (1966) 0.96
An analysis of graft-versus-host disease in Syrian hamsters. I. The epidermolytic syndrome: description and studies on its procurement. J Exp Med (1970) 0.94
Immune hemolysis: a feature of secondary disease and runt disease in the rabbit. Ann N Y Acad Sci (1960) 0.94
Partial identification of a delayed reaction effector substance from homologous lymphoid cell mixtures. Transplant Proc (1969) 0.82
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol (1980) 4.00
Lymphocytes and transplantation immunity. Adv Immunol (1967) 2.73
The role of afferent lymphatics in the rejection of skin homografts. J Exp Med (1968) 2.60
Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci (1991) 2.37
The biology of graft-versus-host reactions. Harvey Lect (1968) 2.35
Immunologically privileged sites. Adv Immunol (1977) 2.35
Distribution of fibronectin during wound healing in vivo. J Invest Dermatol (1981) 2.14
Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply. Transplantation (1992) 2.11
Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol (1990) 2.10
Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci (1996) 2.01
Immunobiology of mammalian reproduction. Adv Immunol (1971) 2.00
Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med (1983) 1.94
The passenger cell concept in transplantation immunology. Cell Immunol (1971) 1.86
Thy-1 antigen-bearing dendritic cells populate murine epidermis. J Invest Dermatol (1983) 1.76
Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol (1986) 1.67
Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J Immunol (1977) 1.65
Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med (1981) 1.63
Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J Immunol (1978) 1.59
TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol (1998) 1.59
Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol (1983) 1.54
Graft-versus-Host reactions: a review. Adv Immunol (1976) 1.53
cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J Immunol (1992) 1.50
Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis. J Invest Dermatol (1991) 1.48
Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res (1992) 1.47
'Actively acquired tolerance' of foreign cells. 1953. J Immunol (2010) 1.46
Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci (2001) 1.44
Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol (1991) 1.43
Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol (1992) 1.41
Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol (1991) 1.39
Studies on delayed cutaneous inflammatory reactions elicited by inoculation of homologous cells into hamsters' skins. J Exp Med (1966) 1.39
Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization. J Invest Dermatol (1980) 1.39
Corneal allografts fail to express Ia antigens. Nature (1979) 1.38
Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J Immunol (1985) 1.38
Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg Immunol (1993) 1.36
In vitro studies on the T-lymphocyte population of human milk. J Exp Med (1976) 1.34
Further evidence concerning the autoantigenic status of the trophoblast. J Exp Med (1972) 1.34
FACS purification of bone marrow-derived epidermal populations in mice: Langerhans cells and Thy-1+ dendritic cells. J Invest Dermatol (1985) 1.34
Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility. Immunogenetics (1990) 1.32
Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol (1992) 1.29
Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest Ophthalmol Vis Sci (1981) 1.28
Neonatally tolerant mice fail to react against virus-infected tolerated cells. Nature (1977) 1.27
Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transpl Immunol (1996) 1.26
Immune regulation and the eye: a dangerous compromise. FASEB J (1987) 1.25
Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol (1993) 1.25
IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2000) 1.25
Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol (1994) 1.24
Lymphocyte traffic, T-cell malignancies and the skin. J Invest Dermatol (1978) 1.23
Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. J Immunol (1990) 1.23
Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation (1997) 1.21
Studies on the conservation of epidermal specificies of skin and certain mucosas in adult mammals. J Exp Med (1967) 1.21
Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J Exp Med (1980) 1.21
Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest Ophthalmol Vis Sci (1984) 1.19
Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed (1990) 1.18
The role of regional lymphatics in the skin homograft response. Transplantation (1967) 1.17
Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol (1980) 1.16
Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J Immunol (1993) 1.15
Further studies on the induction of tolerance of skin homografts in rats. J Exp Zool (1966) 1.14
On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol (1997) 1.13
Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci (1998) 1.13
The embryo as a transplant. Sci Am (1974) 1.13
Histoincompatibility and maternal immunological status as determinants of fetoplacental weight and litter size in rodents. J Exp Med (1975) 1.13
Significance of the cellular component of the maternal immunologic endowment in milk. Transplant Proc (1977) 1.13
Langerhans cells: sentinels of skin associated lymphoid tissue. J Invest Dermatol (1980) 1.12
Genetic background and expressivity of histocompatibility genes. Science (1967) 1.12
'Actively acquired tolerance' of foreign cells. 1953. Transplantation (2003) 1.12
Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci (1999) 1.12
Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol (1991) 1.11
Adipose tissue, a neglected factor in aetiology of breast cancer? Lancet (1978) 1.11
T cells recognize minor histocompatibility antigens on H-2 allogeneic cells. J Exp Med (1979) 1.11
Hypothesis: nonspecific polyclonal activation of memory B cells by antigen as a mechanism for the preservation of long term immunologic anamnesis. Cell Immunol (1978) 1.09
Immunoregulatory properties of bone marrow-derived cells in the iris and ciliary body. Immunology (1989) 1.08
Immunologic benefits and hazards of milk in maternal-perinatal relationship. Ann Intern Med (1975) 1.07
Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. Curr Eye Res (1997) 1.07
Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology (1990) 1.07
Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci (1995) 1.06
Depletion of epidermal langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med (1982) 1.06
Neonatal tolerance induction across regions of H-2 complex. J Immunol (1977) 1.06
Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Vis Sci (1998) 1.05
Autoimmunity in the eye and its regulation. Curr Opin Immunol (1994) 1.05
Do immunologically privileged sites require a functioning spleen? Nature (1974) 1.04
Tolerance or hypersensitivity to 2,4-dinitro-1-fluorobenzene: the role of Langerhans cell density within epidermis. J Invest Dermatol (1980) 1.04
Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J Immunol (1992) 1.04
Proceedings: The immunologic significance of the mammary gland. J Invest Dermatol (1974) 1.04
Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation (1996) 1.04
In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci (2000) 1.04
Skeletal muscle as a privileged site for orthotopic skin allografts. J Exp Med (1973) 1.04
Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci (2001) 1.03
Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J Immunol (1983) 1.02
Evidence for antigen-specific immune deviation in patients with acute retinal necrosis. Arch Ophthalmol (2001) 1.02
Elicitation and expression of transplantation immunity in the uterus. Transplant Proc (1971) 1.00
Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci (1993) 1.00
Two waves of virus following anterior chamber inoculation of HSV-1. Invest Ophthalmol Vis Sci (1987) 1.00
Influence of the Ag-B locus on reactivity to skin homografts and tolerance responsiveness in rats. Transplantation (1969) 0.99
Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci (1997) 0.99
Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation. Curr Eye Res (1983) 0.99
Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells. J Immunol (1975) 0.99
Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye. Transplantation (1982) 0.99
Imposing deviant immunity on the presensitized state. J Immunol (1994) 0.98